In EVs, the concentration of RANTES gradually increased with CSC treatment, HIV-infection, and with both CSC treatment and HIV infection, compared to control U937 EVs, which was statistically significant in all groups (Fig 4B). This evidence concerns the gene CCL5 and HIV infectious disease.